OpenBilldrug price receipt

NADAC week of 2026-10-14

ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML

For 1 unit (EA)

Pharmacies pay

$639.19 filed

1 × $639.19458 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$740.07 estimated

$639.19 + $95.88 (15%) + $5.00 fee per fill = $740.07

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML is how the CMS NADAC file names this product. The FDA NDC Directory lists it as adalimumab-adbm.

FDA gives its dosage form as kit.

Its labelers, the companies named on the label, are Boehringer Ingelheim Pharmaceuticals, Inc. and QUALLENT PHARMACEUTICALS HEALTH LLC.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $639.19 for 1 unit (EA) (1 × $639.19458 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 2 NDCs

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name adalimumab-adbm with ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML.

ProductPharmacies pay per unitMedicare per unit
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML this page
generic · kit
$639.19458 per EA filed
eff. 2026-09-23
We don’t know yet
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.8 ML
generic · kit
$639.57857 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists its 2 NDCs as dosage form “KIT” with no route. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.